Category: Latest News

  • Joby Aviation Shares Jump on Plan to Add Blade Flights to Uber App

    Joby Aviation Shares Jump on Plan to Add Blade Flights to Uber App

    Joby Aviation, Inc. (NYSE:JOBY) saw its stock climb 7.5% after announcing plans to integrate Blade’s air mobility services into the Uber app as early as next year. The move extends Joby’s strategic partnership with Uber Technologies, Inc. (NYSE:UBER) and comes on the heels of its recent acquisition of Blade’s passenger operations. Through the integration, Uber…

  • Avidity Shares Climb on Promising DMD44 Trial Results for Del-zota

    Avidity Shares Climb on Promising DMD44 Trial Results for Del-zota

    Avidity Biosciences (NASDAQ:RNA) gained 2% on Wednesday after releasing fresh clinical data showing that its experimental therapy del-zota reversed disease progression in patients with Duchenne muscular dystrophy (DMD44). The San Diego-based biotech said that patients who received del-zota continuously for about one year in the EXPLORE44 and EXPLORE44-OLE studies experienced “unprecedented improvement” across several functional…

  • Chewy Stock Slides After Q2 Results Fall Short of Expectations

    Chewy Stock Slides After Q2 Results Fall Short of Expectations

    Chewy, Inc. (NYSE:CHWY) saw its shares sink more than 7% on Wednesday after reporting second-quarter earnings that came in line with Wall Street forecasts and a modest revenue beat, but failed to deliver the upside investors had been hoping for. The online pet retailer reported adjusted EPS of $0.33, matching analyst estimates, while revenue reached…

  • CAMP4 Therapeutics Shares Triple After Securing $100M Private Placement

    CAMP4 Therapeutics Shares Triple After Securing $100M Private Placement

    CAMP4 Therapeutics Corporation (NASDAQ:CAMP) saw its stock skyrocket 200% after announcing an oversubscribed private placement that could raise up to $100 million to support its lead program targeting SYNGAP1-related disorders. The biotech firm has already raised $50 million upfront through sales of common stock at $1.53 per share and pre-funded warrants. An additional $50 million…

  • NIO Stock Slides After Announcing 182 Million Share Sale

    NIO Stock Slides After Announcing 182 Million Share Sale

    NIO Inc. (NYSE:NIO) shares tumbled 8.3% in premarket trading Wednesday after the Chinese EV manufacturer unveiled plans for a sizable equity raise. The Shanghai-based company said it will issue roughly 182 million Class A ordinary shares, with underwriters granted a 30-day option to purchase up to 27 million additional depositary receipts. NIO said it plans…

  • Amylyx Pharmaceuticals Stock Slips After Discounted $175M Share Sale

    Amylyx Pharmaceuticals Stock Slips After Discounted $175M Share Sale

    Amylyx Pharmaceuticals (NASDAQ:AMLX) saw its shares retreat more than 4% in premarket trading Wednesday following the announcement of a new equity raise. The Cambridge, Massachusetts-based biotech priced a follow-on offering of 17.5 million shares at $10 apiece, marking a 4.9% discount to Tuesday’s closing price. The sale brings in roughly $175 million in gross proceeds.…

  • TSMC posts nearly 34% jump in August sales amid AI chip boom

    TSMC posts nearly 34% jump in August sales amid AI chip boom

    Taiwan Semiconductor Manufacturing Corp, or TMSC, (NYSE:TSM) reported on Wednesday that its August revenue surged almost 34%, driven by soaring demand for AI-related chips, reinforcing its position as the world’s largest contract semiconductor manufacturer. The company said August sales reached T$335.77 billion ($11.09 billion), a 33.8% increase year-on-year. For the January-August period, revenue climbed 37.1%…

  • Fifth Third Bancorp shares drop after potential $200M fraud uncovered

    Fifth Third Bancorp shares drop after potential $200M fraud uncovered

    Shares of Fifth Third Bancorp (NASDAQ:FITB) fell 2.7% in after-hours trading on Tuesday after the Cincinnati-based bank revealed it may face losses of up to $200 million due to alleged fraud involving a commercial borrower. The lender reported it identified “alleged external fraudulent activity” linked to an asset-backed finance loan with an outstanding balance near…

  • Rubrik shares dip despite smaller-than-expected quarterly loss

    Rubrik shares dip despite smaller-than-expected quarterly loss

    Rubrik (NYSE:RBRK) saw its shares fall more than 4% in premarket U.S. trading Tuesday, even after reporting a quarterly loss narrower than anticipated and providing an optimistic outlook. Analysts at BMO Capital Markets noted that net new subscription annual recurring revenue (ARR) — which reflects sales from new clients and upgrades minus revenue lost from…

  • Synopsys shares plunge 20% as IP headwinds weigh on Q3 results and soft outlook

    Synopsys shares plunge 20% as IP headwinds weigh on Q3 results and soft outlook

    Synopsys (NASDAQ:SNPS) saw its stock drop sharply Tuesday after posting third-quarter results that missed analyst forecasts, alongside soft guidance for the upcoming quarter. The decline reflects ongoing pressure from U.S. restrictions on chipmaking equipment sales to China, which dampened demand. Shares fell nearly 20% in premarket trading Wednesday following the report. For the quarter ending…